3
IRUS TotalDownloads
Infliximab and tofacitinib attenuate neutralizing antibody responses against SARS-CoV-2 ancestral and Omicron variants in IBD patients following 3 doses of COVID-19 vaccine
| File | Description | Size | Format | |
|---|---|---|---|---|
 1-s2.0-S0016508522011842-main.pdf | Published version | 352.76 kB | Adobe PDF | View/Open |
| Title: | Infliximab and tofacitinib attenuate neutralizing antibody responses against SARS-CoV-2 ancestral and Omicron variants in IBD patients following 3 doses of COVID-19 vaccine |
| Authors: | Liu, Z Alexander, J LIN, K Pollock, K Powell, N |
| Item Type: | Journal Article |
| Issue Date: | Feb-2023 |
| Date of Acceptance: | 12-Oct-2022 |
| URI: | http://hdl.handle.net/10044/1/100121 |
| DOI: | 10.1053/j.gastro.2022.10.010 |
| ISSN: | 0016-5085 |
| Publisher: | Elsevier |
| Start Page: | 300 |
| End Page: | 303.e3 |
| Journal / Book Title: | Gastroenterology |
| Volume: | 164 |
| Issue: | 2 |
| Copyright Statement: | © 2023 The Author(s). Published by Elsevier Inc. on behalf of the AGA Institute. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
| Publication Status: | Published |
| Online Publication Date: | 2022-10-19 |
| Appears in Collections: | Department of Metabolism, Digestion and Reproduction Department of Surgery and Cancer Department of Infectious Diseases Faculty of Medicine Imperial College London COVID-19 |
This item is licensed under a Creative Commons License
